A pilot study to examine the effectiveness, safety and tolerability of quetiapine in the treatment of anorexia nervosa in young people
Not Applicable
Completed
- Conditions
- Anorexia NervosaMental Health - Eating disorders
- Registration Number
- ACTRN12609000521224
- Lead Sponsor
- Astra Zeneca Australia
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
A Diagnostic and Statistical Manual for Psychiatric Disorders IV (DSM-IV) diagnosis of anorexia nervosa
No history of treatment with an atypical antipsychotic, though treatment for less than 7 days was considered acceptable
Exclusion Criteria
Treatment with an atypical antipsychotic drug for longer than 7 days, comorbid psychotic illness, history of brain infarction or brain surgery, diabetes, an intelligence quotient (IQ) of less than 70
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method